George Yohrling, Ph.D Discusses Current and Potential HD Treatment Options
George Yohrling, PhD discusses treatment for Huntington's disease patients, therapies in the pipeline and why it’s an exciting time for the research community.
Being Patient-Facing in the Huntington's Disease Space
New Gene Linked to Huntington's Disease Progression
Results from a recent study published in Lancet Neurology by researchers in England and Wales identifies a gene linked to Huntington’s disease progression.
Gene Therapy for Huntington's Disease in Development
In Huntington's disease animal models, AMT-130, an AAV5 vector carrying a DNA cassette encoding artificial micro-RNA, is effective.
Discussing the Importance of the HDSA
Louise Vetter, CEO of the HDSA and George Yohrling, PhD discuss the creation of the organization, what motivates them, and why their work is so important.
Exploring Huntington's Disease with the HDSA
CEO of HDSA Louise Vetter and George Yohrling PhD discuss the pathophysiology and science of HD and why it can be so difficult to recognize, diagnose and treat.
School Principal Walking Across Canadian Province for Huntington's Disease
After losing his mother-in-law to Huntington's disease (HD) in April, Greg Shwaga is using his summer break to raise funds and awareness for this rare condition.
MLB Trade Brings Relief Pitcher Closer to His Mother, a Huntington's Disease Patient
The Toronto Blue Jays traded pitcher Joe Smith to his hometown Cleveland Indians because he requested to be closer to his mother, a Huntington's disease patient.
Jarrius Reports to New Orleans Saints Training Camp
All 32 NFL teams reported to training camp this week, and the New Orleans Saints did so with biliary atresia patient Jarrius Robertson.
11-Year Old Huntington's Disease Patient All Shook Up After Meeting Elvis Impersonator
11-year old Huntington's disease patient Aidan Smith met an Elvis Presley impersonator at the Madonna Rehabilitation Hospital's Lincoln campus this week.
<< Prev Page
Next Page >>
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.